ATE265212T1 - Verwendung von 4-acylaminopyridin derivaten zur herstellung eines medikaments für die behandlung von zerebrovaskulären erkrankungen - Google Patents

Verwendung von 4-acylaminopyridin derivaten zur herstellung eines medikaments für die behandlung von zerebrovaskulären erkrankungen

Info

Publication number
ATE265212T1
ATE265212T1 AT95931437T AT95931437T ATE265212T1 AT E265212 T1 ATE265212 T1 AT E265212T1 AT 95931437 T AT95931437 T AT 95931437T AT 95931437 T AT95931437 T AT 95931437T AT E265212 T1 ATE265212 T1 AT E265212T1
Authority
AT
Austria
Prior art keywords
cerebrovascular diseases
medication
treatment
production
acylaminopyridine derivatives
Prior art date
Application number
AT95931437T
Other languages
English (en)
Inventor
Ken Saito
Tomoko Bessho
Satoshi Yuki
Haruyuki Chaki
Mitsuo Egawa
Original Assignee
Mitsubishi Chem Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Chem Corp filed Critical Mitsubishi Chem Corp
Application granted granted Critical
Publication of ATE265212T1 publication Critical patent/ATE265212T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4741—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT95931437T 1994-09-21 1995-09-19 Verwendung von 4-acylaminopyridin derivaten zur herstellung eines medikaments für die behandlung von zerebrovaskulären erkrankungen ATE265212T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP6227085A JPH0892100A (ja) 1994-09-21 1994-09-21 神経系障害の治療および予防薬
PCT/JP1995/001861 WO1996009058A1 (en) 1994-09-21 1995-09-19 Remedy and preventive for nervous system disorder

Publications (1)

Publication Number Publication Date
ATE265212T1 true ATE265212T1 (de) 2004-05-15

Family

ID=16855273

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95931437T ATE265212T1 (de) 1994-09-21 1995-09-19 Verwendung von 4-acylaminopyridin derivaten zur herstellung eines medikaments für die behandlung von zerebrovaskulären erkrankungen

Country Status (9)

Country Link
US (1) US5952337A (de)
EP (1) EP0782857B1 (de)
JP (1) JPH0892100A (de)
KR (1) KR100362301B1 (de)
AT (1) ATE265212T1 (de)
CA (1) CA2202526A1 (de)
DE (1) DE69532963T2 (de)
ES (1) ES2219664T3 (de)
WO (1) WO1996009058A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001240543A (ja) * 2000-02-29 2001-09-04 Mitsubishi-Tokyo Pharmaceuticals Inc 虚血性網膜疾患並びに網膜及び視神経障害の治療及び／または予防薬
CA2456594A1 (en) * 2001-08-06 2003-02-20 Mitsubishi Pharma Corporation Preventives/remedies for cholinergic neuropathy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2546919B2 (ja) * 1989-11-08 1996-10-23 三菱化学株式会社 ９ーアシルアミノテトラヒドロアクリジン誘導体
CA2029497C (en) * 1989-11-08 2002-06-04 Kunihiro Ninomiya (Deceased) 4-acylaminopyridine derivative

Also Published As

Publication number Publication date
DE69532963T2 (de) 2004-09-02
CA2202526A1 (en) 1996-03-28
EP0782857B1 (de) 2004-04-28
EP0782857A1 (de) 1997-07-09
WO1996009058A1 (en) 1996-03-28
ES2219664T3 (es) 2004-12-01
JPH0892100A (ja) 1996-04-09
DE69532963D1 (de) 2004-06-03
KR100362301B1 (ko) 2003-02-17
KR970706005A (ko) 1997-11-03
US5952337A (en) 1999-09-14
EP0782857A4 (de) 2000-07-26

Similar Documents

Publication Publication Date Title
ATE133667T1 (de) Thiazolderivate, verfahren zur ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten
NL930077I1 (nl) Gesubstitueerde acylderivaten van 1,2,3,4-tetrahydroisochinoline-3-carbonzuren zouten ervan farmaceutische preparaten die de derivaten of zouten bevaaten en de bereiding daarvan
DE3875285D1 (de) Verwendung von salzen der n-acetylneuraminsaeure zur herstellung eines arzneimittels zum abschwellen der nasenschleimhaut.
ATE33835T1 (de) Verbindung mit antibronchopneumopathischer wirkung, verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ES2071725T3 (es) Diesteres fosfato de acido ascorbico y tocoferilo para la inhibicion de la reaccion de maillard.
HU9603433D0 (en) Novel 4-6-diaryl-pyrimidine-derivatives and salts thereof
ATE26212T1 (de) Verwendung von amino-phenylessigs ure-derivaten zur herstellung eines immunomodulatoren arzneimittels.
ATE184483T1 (de) Spirooxathiolan-quinuclidin-derivat zur behandlung des sjögren-syndroms
DE60011462D1 (de) Aralkyl-1,2-diaminen mit calcimimetischer wirkung und verfahren zu ihrer herstellung
DE3873578D1 (de) Verwendung von tetrahydrobenz(c,d)indol-6-carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
DE3888340D1 (de) Verwendung von 1,4-disubstituierten-Piperidinyl-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung von Schlaflosigkeit.
DE68908145D1 (de) Verwendung von l-carnitinderivaten zur herstellung eines arzneimittels zur therapeutischen behandlung von peripheren neuropathien.
ATE62222T1 (de) Aminosaeure-derivate und ihre anwendung zur herstellung eines antikrampfmittels.
ATE206926T1 (de) Verwendung eines phosphorsäurediesters zur herstellung eines arzneimittels zur behandlung von akne
ATE420853T1 (de) 5-amidino-2-hydroxybenzolsulfonamidderivate, pharmazeutischen zusammensetzungen, die diese verbindungen enthalten, und zwischenprodukte zu deren herstellung
ATE89739T1 (de) Entzuendungshemmende und/oder antiallergische zusammensetzung, die glutathionderivate enthaelt.
KR910000647A (ko) 나프틸아미노-및 나프틸옥시- 피리딘아민 및 관련된 화합물, 이의 제조방법 및 이의 피부소염제로서의 용도
ATE135573T1 (de) Verwendung von indazol-methoxyalkansäure zur herstellung eines arzneimittels zur behandlung von autoimmunkrankheiten
ATE69049T1 (de) Chinazolin-derivat, verfahren zu dessen herstellung und mittel zur behandlung von cerebraler disfunktion als aktiver inhaltsstoff.
ATE265212T1 (de) Verwendung von 4-acylaminopyridin derivaten zur herstellung eines medikaments für die behandlung von zerebrovaskulären erkrankungen
ATE38982T1 (de) Guanidinmethylcyclohexancarbonsaeure-derivate, verfahren zur herstellung und pharmazeutische mittel.
ATE181503T1 (de) Verwendung von idazoxan und derivaten zur herstellung eines arzneimittels zur behandlung von parkinsonismus und seiner evolution
ATE168690T1 (de) Indolderivate, ihre salze und sie enthaltende arzneimittel zur behandlung von herzkrankheiten
RU94033470A (ru) Циклогексановые производные, фармкомпозиция на их основе и способ лечения
HUT50628A (en) Process for producing pharmaceutical compositions comprising retinoid

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties